Biology, engineered.
Patients, first.
We develop engineered biological payload therapeutics around unmet clinical needs—connecting scientific insight, programmable biology and translational development.
A new chapter in
therapeutic development.
Start with the need.
Engineer the possibility.
LotusLake Biomedical is a Beijing-based biotechnology company developing innovative therapies at the intersection of mRNA, engineered cells and extracellular vesicles.
Meet LotusLakeOur mission is to
extend human healthspan.
We bring clinicians, scientists and engineers together to turn well-defined clinical challenges into testable product concepts. Each step connects the intended patient benefit to a biological mechanism, a manufacturable product and the evidence needed to move forward.
- 01
Clinical need
Define the patient, unmet need and meaningful outcome.
- 02
Target validation
Combine scientific evidence, computational models and experiments.
- 03
Product engineering
Match payload, biological chassis, delivery and dose.
- 04
Translational evidence
Build the package for clinical development and partnership.
One therapeutic idea.
Four design dimensions.
Engineered Biological Payload Therapeutics (EBPT) brings payload, biological chassis, delivery and dose into one product design.
Distinct needs.
A shared engineering approach.
Our research spans regenerative medicine, vascular disease and tissue repair. Each candidate is developed against its own product definition and evidence requirements.
View the pipeline
FGF18–MSC
Investigating an mRNA-engineered cell approach to deliver FGF18 for cartilage repair and joint preservation.
Preclinical development
Decorin–EV
Exploring Decorin-associated extracellular vesicles and inhaled delivery for pulmonary fibrosis.
Product design & preclinical evaluation
VEGFA–MSC
Developing a VEGFA-based engineered cell approach to investigate vascular regeneration and tissue repair.
Translational developmentDevelopment snapshot · September 2026. All featured candidates remain investigational.
Ideas need a path
to a real product.
Our foundation in process development, analytical methods and manufacturing supports the transition from a biological concept to a reproducible therapeutic candidate.
Explore our capabilitiesProcess & product development
mRNA, cells, extracellular vesicles and gene delivery platforms.
Quality by design
Product identity, potency, consistency and traceability.
Translational collaboration
Clinical questions, meaningful endpoints and study readiness.
Better questions.
Better possibilities.
Bring a clinical challenge, a scientific discovery or a development ambition. Let’s explore what we can build together.
Start a conversation